INHSU 2022

19-21 October 2022

Glasgow, Scotland + Virtual

Epidemiology and public health in hepatitis C, other infectious diseases, and the broader health of people who use drugs.

Register now


INHSU 2022 Co-Convenors


INHSU 2022’s committee features some of the leading experts in epidemiology and public health in hepatitis C, other infectious diseases, and the broader health of people who use drugs.

Jason Grebely

Jason Grebely is the President of INHSU and a Professor in the Viral Hepatitis Clinical Research Program at the Kirby Institute, UNSW Sydney. Jason’s training and research is based in the field of epidemiology, with a specific focus on clinical epidemiology. 

Judy Chang

Judy Chang

Judy Chang is the Executive Director of the International Network of People who Use Drugs (INPUD). Judy has worked in the HIV and community-based health and development field for thirteen years. She brings 20 years of lived experience as a woman who uses drugs and a client of harm reduction services to her role. Prior to 2015, her primary area of focus was on community health before moving to harm reduction and drug policy advocacy. During the course of her work, she has worked in various contexts, such as India, China and Thailand.

John Dillon

John Dillon

Prof John Dillon is Professor of Hepatology and Gastroenterology and a principle investigator, in the Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, based at Ninewells hospital, Dundee. He is also an Honorary Consultant with NHS Tayside, leading a busy general hepatology service and a research group. He is Vice President for Hepatology of the British Society of Gastroenterology and was President of the Scottish Society of Gastroenterology.

Rachel Halford

Rachel Halford is the Chief Executive of the Hepatitis C Trust. She has over 20 years’ experience of working with people at high-risk of viral hepatitis, and liver disease generally – the homeless, prisoners, substance users and migrants. The past 18 years of which have been in senior management roles within the voluntary/ NGO sector.

Passionate about equality and human rights, Rachel joined The Hepatitis C Trust in 2015 as Deputy CEO, before taking over as CEO in July 2018.

Matt Hickman

Matt Hickman is the Head of Population Health Sciences and Deputy Head of Bristol Medical School. Matt is a NIHR Senior Investigator and Professor in Public Health and Epidemiology and Director of NIHR Health Protection Research Unit in Behavioural Science and Evaluation.

Sharon Hutchinson

Sharon Hutchinson

Sharon Hutchinson is a Professor of Epidemiology and Population Health at Glasgow Caledonian University and Consultant Scientist at Public Health Scotland. She has 25 years experience in conducting epidemiological research informing the design and impact of public health interventions. Authoring over 230 publications, she leads a broad translational research programme on the prevention, diagnosis, and treatment of hepatitis C (HCV) and other blood-borne viruses with particular focus on people who inject drugs.

David Liddell

David Liddell is the CEO of the Scottish Drugs Forum. He has worked for Scottish Drugs Forum since its inception in 1986 and in the field of drugs, alcohol and homelessness for over 35 years in England, Ireland and Scotland. He served on the UK Government’s Advisory Council on the Misuse of Drugs from 2008 until 2017. He is a Board Member of the national anti-poverty network in Scotland, The Poverty Alliance.